http://www.ukmanchester.com/user_detail.php?u=neeriasar
Beating out the Triangle in the rankings were greater Philadelphia, greater San Francisco and greater New York. The titled “The Greater Philadelphia Life SciencedsCluster 2009,” updates the institute’w 2005 study, which also had Raleigh-Durham in the fifth spot overall. The repor t said Raleigh-Durham “substantially outperforms the nationapl average with strongemployment concentration.” The regionj ranked first for employment concentration in both the therapeuticss and devices category as well as the biotechnology category. The cluste of hospitals, medical centers and universitiez helped the Triangle rank second in researcnand development.
But Raleigh-Durhak did not rank high in venture capital, placing No. 10 out of the 11 regionss in the study. The institute says the purpose of the studgy is to definegreater Philadelphia’s opportunities and challenges in the life sciences. Chriw Brodie, a spokesman for the , said it is gratifyinyg to see that the Triangle ranks among the top biotecjh hubs inthe U.S. and the world. But he addedc that these rankings fail to captureNort Carolina's statewide biotechnology strengths. "In additio to (Research Triangle we've got emerging clusters in the Triadand Kannapolis/Charlottr areas and strong regional development in Greenville and Asheville," he said.
Regarding the Triangle'xs low ranking for venture capital, Brodide said that in this downturn, it's harder to find that suppor anywhere. He added that the Biotechnology Cente r has several loan programs that can help startups bridge gaps intraditionapl funding.
No comments:
Post a Comment